LAVA Therapeutics
LVTX
LVTX
20 hedge funds and large institutions have $26.3M invested in LAVA Therapeutics in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
+7
Holders Change %
+53.85%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
1
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$606K |
2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$343K |
3 |
Millennium Management
New York
|
-$179K |
4 |
AWG
Alpha Wave Global
New York
|
-$5.87K |
5 |
Axa
Paris,
France
|
-$4.17K |